Cliff Asness's MRVI Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 111,131 shares of Maravai LifeSciences Holdings, Inc. (MRVI) worth $361,177, representing 0.00% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in MRVI, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 1.76 M shares. Largest reduction occurred in Q2 2024, reducing 2.05 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Maravai LifeSciences Holdings (MRVI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Maravai LifeSciences Holdings (MRVI) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +49,551 | Add 80.47% | 111,131 | $3.25 |
| Q3 2025 | +1,740 | Add 2.91% | 61,580 | $2.87 |
| Q2 2025 | +44,313 | Add 285.39% | 59,840 | $2.41 |
| Q1 2025 | -35,835 | Reduce 69.77% | 15,527 | $2.21 |
| Q4 2024 | -268,107 | Reduce 83.92% | 51,362 | $5.45 |
| Q3 2024 | -453,544 | Reduce 58.67% | 319,469 | $8.31 |
| Q2 2024 | -2.05 M | Reduce 72.65% | 773,013 | $7.16 |
| Q1 2024 | -678,236 | Reduce 19.36% | 2.83 M | $8.58 |
| Q4 2023 | +1.76 M | Add 100.35% | 3.5 M | $6.55 |
| Q3 2023 | +779,838 | Add 80.46% | 1.75 M | $9.84 |
| Q2 2023 | -322,889 | Reduce 24.99% | 969,165 | $12.43 |
| Q1 2023 | -168,598 | Reduce 11.54% | 1.29 M | $13.93 |
| Q4 2022 | +602,852 | Add 70.28% | 1.46 M | $14.25 |
| Q3 2022 | +264,660 | Add 44.62% | 857,800 | $25.53 |
| Q2 2022 | +441,489 | Add 291.12% | 593,140 | $27.11 |
| Q1 2022 | +146,519 | Add 2855.01% | 151,651 | $35.27 |
| Q4 2021 | +5,132 | New Buy | 5,132 | $41.89 |
Cliff Asness's Maravai LifeSciences Holdings Investment FAQs
Cliff Asness first purchased Maravai LifeSciences Holdings, Inc. (MRVI) in Q4 2021, acquiring 5,132 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Maravai LifeSciences Holdings, Inc. (MRVI) for 17 quarters since Q4 2021.
Cliff Asness's largest addition to Maravai LifeSciences Holdings, Inc. (MRVI) was in Q4 2023, adding 3,504,111 shares worth $22.95 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 111,131 shares of Maravai LifeSciences Holdings, Inc. (MRVI), valued at approximately $361,177.
As of the Q4 2025 filing, Maravai LifeSciences Holdings, Inc. (MRVI) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Maravai LifeSciences Holdings, Inc. (MRVI) was 3,504,111 shares, as reported at the end of Q4 2023.